Jose Tinajero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California, San FranciscoPharmD, 2019
Publications & Presentations
PubMed
- 4 citationsTreatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib.Dat Ngo, Jose Tinajero, Shanpeng Li, Joycelynne Palmer, Hoda Pourhassan
Leukemia & Lymphoma. 2024-03-01 - 3 citationsDosing of 3 Targeted Agents in Novel Drug Combinations Used at the Precision Medicine Clinic of the University of California San Diego.Mina Nikanjam, Jose Tinajero, Mary McGann, Jerry Li, Jincheng Yang
Journal of Hematology Oncology Pharmacy. 2023-02-01 - 3 citationsThe impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospecti...Dat Ngo, Jason Chen, Jose Tinajero, Ahmed Aribi, Shukaib Arslan
Stem Cell Research & Therapy. 2023-04-18
Office
601 S Wolfe St
Baltimore, MD 21231
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: